Aluminum n-octacosoxideCAS# 67905-27-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 67905-27-5 | SDF | Download SDF |
PubChem ID | 106032 | Appearance | Powder |
Formula | C84H171AlO3 | M.Wt | 1256.2 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | aluminum;octacosan-1-olate | ||
SMILES | CCCCCCCCCCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCCCCCCCCCC[O-].[Al+3] | ||
Standard InChIKey | WFYYEDFTTMWDQX-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/3C28H57O.Al/c3*1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-28-29;/h3*2-28H2,1H3;/q3*-1;+3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Aluminum n-octacosoxide Dilution Calculator
Aluminum n-octacosoxide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 0.7961 mL | 3.9803 mL | 7.9605 mL | 15.921 mL | 19.9013 mL |
5 mM | 0.1592 mL | 0.7961 mL | 1.5921 mL | 3.1842 mL | 3.9803 mL |
10 mM | 0.0796 mL | 0.398 mL | 0.7961 mL | 1.5921 mL | 1.9901 mL |
50 mM | 0.0159 mL | 0.0796 mL | 0.1592 mL | 0.3184 mL | 0.398 mL |
100 mM | 0.008 mL | 0.0398 mL | 0.0796 mL | 0.1592 mL | 0.199 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Ambrox
Catalog No.:BCN6907
CAS No.:6790-58-5
- Scutebarbatine K
Catalog No.:BCN3223
CAS No.:960302-86-7
- Cyclo(Pro-Trp)
Catalog No.:BCN2422
CAS No.:67889-75-2
- Gigantol
Catalog No.:BCN8382
CAS No.:67884-30-4
- n-Butyl-β-D-fructopyranoside
Catalog No.:BCC9097
CAS No.:67884-27-9
- Martynoside
Catalog No.:BCN4236
CAS No.:67884-12-2
- Deapi-platycodin D3
Catalog No.:BCN3240
CAS No.:67884-05-3
- Glycosolone
Catalog No.:BCN6521
CAS No.:67879-81-6
- Caftaric acid
Catalog No.:BCN2096
CAS No.:67879-58-7
- Boc-Nva-OH.DCHA
Catalog No.:BCC2642
CAS No.:67861-96-5
- Taraxasterone
Catalog No.:BCN7746
CAS No.:6786-16-9
- Ethyl 2,4-dihydroxyphenylacetate
Catalog No.:BCN4235
CAS No.:67828-62-0
- Dehydroevodiamine
Catalog No.:BCN2974
CAS No.:67909-49-3
- Homobaldrinal
Catalog No.:BCN2681
CAS No.:67910-07-0
- Macusine B
Catalog No.:BCN6471
CAS No.:6792-07-0
- Mesaconine
Catalog No.:BCC8339
CAS No.:6792-09-2
- 1,6-Dihydro-4,7'-epoxy-1-methoxy-3',4'-methylenedioxy-6-oxo-3,8'-lignan
Catalog No.:BCN6584
CAS No.:67920-48-3
- Sodium Danshensu
Catalog No.:BCN5952
CAS No.:67920-52-9
- Aurantio-obtusin
Catalog No.:BCN1222
CAS No.:67979-25-3
- N-(5,8,11,14-Eicosatetraenoyl)taurine
Catalog No.:BCN1755
CAS No.:679834-28-7
- N-(15-Methyl-9-hexadecenoyl)taurine
Catalog No.:BCN1754
CAS No.:679834-30-1
- BMS 193885
Catalog No.:BCC7613
CAS No.:679839-66-8
- Sodium citrate
Catalog No.:BCC7588
CAS No.:68-04-2
- Vitamin B12
Catalog No.:BCC4878
CAS No.:68-19-9
GC-MS Analysis and Preliminary Antimicrobial Activity of Albizia adianthifolia (Schumach) and Pterocarpus angolensis (DC).[Pubmed:28930113]
Medicines (Basel). 2016 Jan 28;3(1). pii: medicines3010003.
The non-polar components of two leguminoceae species Albizia adianthifolia (Schumach), and Pterocarpus angolensis (DC) were investigated. GC-MS analysis of the crude n-hexane and chloroform extracts together with several chromatographic separation techniques led to the identification and characterization (using NMR) of sixteen known compounds from the heartwood and stem bark of Albizia adianthifolia and Pterocarpus angolensis respectively. These constituents include, n-hexadecanoic acid (palmitic acid) 1, oleic acid 2, chondrillasterol 3, stigmasterol 4, 24S 5alpha-stigmast-7-en-3beta-ol 5, 9,12-octadecadienoic acid (Z,Z)-, methyl ester 6, trans-13-octadecanoic acid, methyl ester 7, tetradecanoic acid 8, hexadecanoic acid, methyl ester 9, octadecanoic acid 10, tetratriacontane 11, 7-dehydrodiosgenin 12, lupeol 13, stigmasta-3,5-diene-7-one 14, friedelan-3-one (friedelin) 15, and 1-octacosanol 16. Using agar over lay method, the preliminary antimicrobial assay for the extracts was carried out against bacterial (E. coli, P. aeruginosa, B. subtilis, S. aueus) and a fungus/yeast (C. albicans) strains. The n-hexane and chloroform extracts of A. adianthifolia showed the best activity against E. coli with minimum inhibition quantity (MIQ) of 1 microg each while the remaining exhibited moderate-to-weak activity against the test microorganisms.
Antioxidant, Antibacterial, and Cytotoxic Activities of the Ethanolic Origanum vulgare Extract and Its Major Constituents.[Pubmed:27051475]
Oxid Med Cell Longev. 2016;2016:1404505.
Oregano is a perennial shrub that grows in the mountains of the Mediterranean and Euro/Irano-Siberian regions. This study was conducted to identify the major constituents of the ethanolic Origanum vulgare extract and examine the cytotoxic, antioxidant, and antibacterial properties of the extract but more importantly the contribution of its specific major constituent(s) or their combination to the overall extract biological activity. Gas chromatography/mass spectroscopy analysis showed that the extract contained monoterpene hydrocarbons and phenolic compounds, the major ones being carvacrol and thymol and to a lesser extent p-cymene, 1-octacosanol, creosol, and phytol. A549 epithelial cells challenged with the extract showed a concentration-dependent increase in cytotoxicity. A combination of thymol and carvacrol at equimolar concentrations to those present in the extract was less cytotoxic. The A549 cells pretreated with nonlethal extract concentrations protected against hydrogen-peroxide-induced cytotoxicity, an antioxidant effect more effective than the combination of equimolar concentrations of thymol/carvacrol. Inclusion of p-cymene and/or 1-octacosanol did not alter the synergistic antioxidant effects of the carvacrol/thymol mixture. The extract also exhibited antimicrobial properties against Gram-positive and Gram-negative bacterial strains including clinical isolates. In conclusion, the oregano extract has cytotoxic, antioxidant, and antibacterial activities mostly attributed to carvacrol and thymol.
New lipoxygenase and cholinesterase inhibitory sphingolipids from Carthamus oxyacantha.[Pubmed:26285908]
Nat Prod Res. 2016 Aug;30(16):1787-95.
Two new sphingolipids: oxyacanthin A [(2S,3S,4R)-2-{[(2R,5E)-2-hydroxyoctadec-5-enoyl]amino}hexaeicosane-1,3,4-triol; 1] and B [(2S,3S,4R)-2-{[(2R,5E)-2-hydroxyoctadec-5-enoyl]amino}hexaeicosane-1,3,4-triol-1 -O-beta-D-glucopyranoside; 2], together with 1-octacosanol, beta-sitosterol, beta-sitosterol 3-O-beta-D-glucopyranoside and luteolin 7-O-beta-glucopyranoside were isolated from the methanolic extract of the whole plant of Carthamus oxyacantha. Their structures were elucidated using (1)H and (13)C NMR spectra and 2D NMR analyses (HMQC, HMBC and COSY) in combination with mass spectrometry (EI-MS, HR-EI-MS, FAB-MS and HR-FAB-MS) experiments and in comparison with the literature data of the related compounds. Both the compounds 1 and 2 showed inhibitory potential against lipoxygenase (LOX) in a concentration-dependent manner with IC50 values 83.3 +/- 1.3 and 245.7 +/- 1.1 microM, whereas compound 2 showed inhibition against enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50 values 65.3 +/- 0.1 and 93.6 +/- 0.1 microM, respectively.